Study protocol: a prospective single-center study for non-invasive biomonitoring of renal complications in cancer patients treated with immune checkpoint inhibitors

BACKGROUND: The advent of immune checkpoint inhibitors (ICIs) has powerfully broadened the scope of treatment options for malignancies with an ongoing increase of indications, but immune-related adverse events (irAEs) represent a serious threat to treatment success. Agents directed against programme...

Descripción completa

Detalles Bibliográficos
Autores principales: Baier, Eva, Korsten, Peter, Strauß, Arne, Thoms, Kai-Martin, Overbeck, Tobias, Ströbel, Philipp, Tampe, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169823/
https://www.ncbi.nlm.nih.gov/pubmed/37180131
http://dx.doi.org/10.3389/fimmu.2023.1140677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169823/
https://www.ncbi.nlm.nih.gov/pubmed/37180131
http://dx.doi.org/10.3389/fimmu.2023.1140677

Ejemplares similares